搜索结果: 'methocult media formulations for mouse hematopoietic cells serum containing'
-
STEMCELL Technologies Launches mTeSR™ Plus, a Next-Generation Culture System for Human ES and iPS Cell Maintenance The new medium has undergone successful beta testing with several members of the Stem Cell COREdinates group and has completed rigorous in-house validation testing
-
STEMCELL Technologies Signs Exclusive License with Propagenix to Commercialize EpiX™, an Innovation Empowering Epithelial Cell Biology and Cell Therapy STEMCELL Technologies has signed an exclusive license with Propagenix of Rockville, MD to commercialize its patented EpiX™ technology, a novel and revolutionary cell culture medium that enables unprecedented expansion of tissue-resident epithelial stem cells without any genetic manipulation
-
GE Healthcare expands cell therapy portfolio with license of STEMCELL Technologies’ T-Cell reagents Exclusive licensing agreement will provide cGMP grade reagents to further enable development and manufacturing of cellular immunotherapies
-
Walk Away With A RoboSep™ Facebook Photo Contest Winners STEMCELL Technologies has announced the Grand Prize Winner and Finalists of the “Walk Away With A RoboSep™” Facebook photo contest
-
STEMCELL Submits Drug Master File for mTeSR™1, the Most Widely Published Cell Culture Medium for Human Pluripotent Stem Cells STEMCELL Technologies announced it has filed a Type II Drug Master File (DMF) to the Food and Drug Administration (FDA) for the Cellular Therapy Ancillary Material mTeSR™1 and has been issued DMF# 18339
-
STEMCELL Technologies Signs Exclusive License with IU Innovation and Commercialization Office for Inner Ear Organoid Technology STEMCELL Technologies has signed an exclusive license with Indiana University Innovation and Commercialization Office for patented rights to groundbreaking inner ear organoid technologies
-
STEMCELL Technologies Signs Exclusive License to Commercialize Human Pluripotent Stem Cell-Derived Kidney Organoid Culture System STEMCELL Technologies has today announced that they have signed an exclusive license agreement with Brigham and Women's Hospital for rights to commercialize technologies for the generation of human pluripotent stem cell-derived kidney organoids
-
STEMCELL Technologies Receives Government of Canada Support to Develop New Cell Isolation Technology that will Enable Advancements in the Study of the Immune Response to HIV and the Development of HIV Vaccines STEMCELL Technologies announced that the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) will provide up to $1.5 million in financial support for the development of cell isolation technology that will further basic and translational HIV research as well as broader research in infectious disease
-
Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies STEMCELL and CDI will work together on progressive solutions for the life science tools market